S0924 requires the Florida Department of Management Services to include coverage in the state group health insurance plan for medically necessary fertility preservation services when a covered person is facing cancer treatment that may directly or indirectly cause iatrogenic infertility. The bill applies to policies issued on or after January 1, 2026, and covers standard fertility retrieval and preservation services, including sperm, oocyte, and ovarian tissue cryopreservation, when those services are consistent with nationally recognized clinical practice guidelines.
The bill also limits how the coverage is administered. It prohibits the state group health insurance plan from requiring preauthorization for these fertility preservation services, but allows the plan to apply ordinary benefit design features such as deductibles, copayments, coinsurance, and maximum benefit limits. Coverage for retrieval and storage ends after three years from the procedure date or when the person is no longer covered under the state plan, whichever comes first. The bill defines key terms such as iatrogenic infertility and nationally recognized clinical practice guidelines, and it takes effect July 1, 2025.
Impact
This bill amends section 110.12303, Florida Statutes, by adding a new subsection governing fertility preservation benefits in the state employee health insurance program. Its practical effect is to require the state to fund specified fertility preservation services for eligible employees and dependents undergoing cancer treatment, while setting parameters on duration, covered procedures, and cost-sharing. It does not broadly regulate all private insurance in Florida, but it does authorize health benefit plans to include certain limitations under the stated conditions.
Sentiment
The committee vote history suggests generally favorable support for the bill, with strong majorities in each committee and only one dissenting vote at each stage. The pattern of votes indicates broad agreement that the state should provide fertility preservation coverage for people whose cancer treatment may threaten future fertility. No committee transcript was provided, so the available record shows support through committee action rather than detailed debate.
Contention
The main points of potential contention are the scope and administration of the benefit. Questions may arise over limiting coverage to cancer-related iatrogenic infertility rather than other causes of infertility, the three-year storage cap, and the bill’s allowance for deductibles, copayments, coinsurance, and maximum benefit limits. Another possible issue is the exclusion of preauthorization requirements, which favors easier access for patients but may be viewed by plan administrators as reducing utilization controls. The single dissenting vote in each committee suggests some disagreement, though the record provided does not identify the specific objection.